Related Experiment Videos
[Nonvaccine Streptococcus pneumoniae serotypes causing acute bacterial meningitis]
A Luque Moreno1, A Bergadà Masó, J M Sin Opi
1Servicio de Pediatría, Hospital Universitario de Girona Doctor Josep Trueta, Girona, Spain. DRLUKE69@hotmail.com
Anales De Pediatria (Barcelona, Spain : 2003)
|March 11, 2006
Summary
The pneumococcal conjugate vaccine protects young children from invasive pneumococcal disease. However, vaccine use may lead to a rise in non-vaccine serotype infections, like meningitis.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- The pneumococcal heptavalent conjugate vaccine (PCV7) is highly effective in preventing invasive pneumococcal disease (IPD) in children under two.
- PCV7 targets the most common serotypes responsible for IPD, demonstrating high efficacy in US and European populations.
Observation:
- This report details two cases of pediatric pneumococcal meningitis caused by serotypes not covered by the PCV7 vaccine.
- These cases highlight a potential challenge associated with widespread vaccine implementation.
Findings:
- The PCV7 vaccine provides robust protection against targeted pneumococcal serotypes.
- Infection by non-vaccine serotypes can still occur, as evidenced by the presented meningitis cases.
Implications:
- Widespread PCV7 use may be associated with a shift in the predominant serotypes causing IPD.
- Continued surveillance and potential updates to vaccination strategies are crucial to address evolving pneumococcal epidemiology.